Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178173 · ClinicalTrials.gov registry record · NA
Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT05178173 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 230 participants.
The verdict
NCT05178173, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
Randomized, double-blind prospective trial to test the efficacy of therapeutic, antiseptic mouth rinses to inactivate severe acute respiratory syndrome coronavirus (SARS-CoV-2) in saliva of COVID-19 positive patients aged 18-65 years old. All mouthrinses are commercially available and will be used according to on-label instructions. Patients will be randomized to a mouthrinse and will be asked to give a saliva sample immediately before and after a one minute mouthwash. Saliva samples will be collected from patients at 15 minute intervals thereafter up to an hour (15, 30, 45 and 60 minutes). The samples will be stored and used for real-time reverse transcription polymerase chain reaction (RT-PCR) detection of viral SARS-CoV-2 RNA and viral infectivity assays. Patients will also complete a short-survey on the taste and experience of using the mouthwash. This study involves 150 subject participants and one, 75-90 minute visit.
Interventions
- OTHER Placebo Comparator: Sterile Water
- OTHER 27% Ethanol plus essential oils
- OTHER 0.075% Cetylpyridinium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2022-01-20 |
| Est. Completion | 2023-07-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05178173
The ClinicalTrials.gov registry entry for NCT05178173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Comparator: Sterile Water is the first listed.
NCT05178173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05178173 about?
NCT05178173 is a clinical study titled "Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)". Randomized, double-blind prospective trial to test the efficacy of therapeutic, antiseptic mouth rinses to inactivate severe acute respiratory syndrome coronavirus (SARS-CoV-2) in saliva of COVID-19 positive patients aged 18-65 years old. All mouthrinses are commercially available and will be used a...
What is the current status of trial NCT05178173?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2022-01-20. Estimated completion is 2023-07-12.
What interventions are being tested in trial NCT05178173?
The interventions under investigation include: Placebo Comparator: Sterile Water (OTHER), 27% Ethanol plus essential oils (OTHER), 0.075% Cetylpyridinium Chloride (OTHER).
Who is sponsoring clinical trial NCT05178173?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.